Expert Perspectives: The Role of Immunotherapy in Advancing the Treatment of HCC and BTC
Advances in the Diagnosis, Assessment, and Therapeutic Management of BTC
Addressing the Unmet Needs of Myotonic Dystrophy Type 1 (DM1)
A ACCME Accredited provider.
The France Foundation ©
Chandler Building, 84 Lyme Street, Old Lyme, CT USA